Funding Opportunities

• Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
  (PAR-19-207)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): August 11, 2020, November 17, 2020, March 15, 2021, August 10, 2021, November 15, 2021, March 15, 2022, August 10, 2022
• Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed)
  (PAR-19-208)
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
  (PAR-19-209)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): May 6, 2019; May 6, 2020; May 6, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NINDS Institutional Research Training Program (T32)
  (PAR-19-211)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 29, 2019; June 29, 2020; May 26, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
  (PAR-19-212)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): July 23, 2019; March 23, 2020; July 23, 2020; March 23, 2021, July 23, 2021, March 23, 2022, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
  (PAR-19-213)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): July 23, 2019; March 23, 2020; July 23, 2020; March 23, 2021, July 23, 2021, March 23, 2022, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (PAR-19-214)
  National Institute of Mental Health
  Application Receipt Date(s): June 20, 2019, October 18, 2019, February 20, 2020, June 19, 2020, October 20, 2020, February 19,2021, June 21, 2021, October 20, 2021, February 21, 2022by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
  (PAR-19-215)
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): May 31, 2019; May 28, 2020; May 28, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)
  (PAS-19-210)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2019.
• Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed)
  (RFA-AG-20-013)
  National Institute on Aging
  Application Receipt Date(s): July 2, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed)
  (RFA-AG-20-014)
  National Institute on Aging
  Application Receipt Date(s): July 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
  (RFA-AI-19-028)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)
  (RFA-AI-19-029)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed)
  (RFA-DK-19-501)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): May 15, 2019, by 5:00 PM local time of applicant organization. Alltypes of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-NS-19-015)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): May 6, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.